Shares of TransEnterix (NYSEMKT: TRXC), a medical device company marketing the Senhance robot-assisted surgical system, are plunging again in response to a dismal second-quarter earnings report. Investors disturbed by a lack of new system sales drove the stock 21.7% lower on Thursday. In 2018 Transenterix sold an encouraging 15 Senhance robots.
Full Answer
Is trxC stock a buy after up 1322% in 6 months?
· TRXC stock saw prices dip from $5.41 at the Monday close to $4.64 at the Tuesday open. The stock dropped as low as $3.54 this morning before recovering ahead of the Investor Day presentation to ...
What's going on with trxC's story Count?
· November 10, 2020, 9:00 AM · 4 min read. TransEnterix (TRXC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an ...
Should you buy asensus surgical (trxC) stock?
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc. The name change reflects the company's broader vision of shaping the future of surgery by ...
What does transenterix stock hold sell signals from moving averages?
· But of course, the markets have been choppy lately – especially for hot growth companies. Besides, TRXC stock has already had a powerful run …
What happen to TRXC?
TRXC stock will begin trading under the new name and ticker ASXC on March 5, 2021. The company said, “the name change [to Asensus Surgical] reflects the company's broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.”
Is TRXC a good buy?
TransEnterix currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
Is TRXC a hold?
At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
How much is TRXC worth?
TRXC Price StatisticsTRONCLASSIC Price$0.00002942Price Change24h$0.0000008443 2.95%24h Low / 24h High$0.00002826 / $0.00002942Trading Volume24hNo DataVolume / Market CapNo Data2 more rows
Who invested in TRXC?
Top 10 Owners of Asensus Surgical IncStockholderStakeTotal value ($)SSgA Funds Management, Inc.5.37%7,964,952The Vanguard Group, Inc.4.59%6,802,249First Trust Advisors LP1.85%2,737,055Geode Capital Management LLC1.62%2,405,5516 more rows
What is TRXC stock?
Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided... TRXC : 4.08 (-10.13%)
How do I buy TRXC stock?
Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is Tron Classic a good investment?
Tronclassic (TRXC) Cryptocurrency Market info Our Ai cryptocurrency analyst implies that there will be a positive trend in the future and the TRXC might be good for investing for making money. Since this virtual currency has a positive outlook we recommend it as a part in your portfolio.
How do you convert to Tron Classic?
If you're using Coinbase Wallet extension, tap the “Convert” button. Search for TRONCLASSIC and input the amount of ETH you'd like to exchange for TRONCLASSIC. Remember to leave enough for transaction fees. Confirm your purchase and follow the instructions on the screen to finalize.
How much did Transenterix stock gain in 2021?
The TransEnterix, Inc stock price gained 3.07% on the last trading day (Friday, 9th Jul 2021), rising from $2.61 to $2.69. During the day the stock fluctuated 8.04% from a day low at $2.55 to a day high of $2.76. The price has fallen in 7 of the last 10 days and is down by -16.72% for this period. Volume fell on the last day by -993 thousand shares and in total, 5 million shares were bought and sold for approximately $12.40 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Is Transenterix a negative stock?
TransEnterix, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
What tickers are used in TRXC?
The most mentioned tickers in articles about TRXC are ASC, CE and ATNF.
What is TRXC in research?
RESEARCH TRIANGLE PARK, N.C.-- (BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff throughout Europe with basic and advanced training on the Senhance® Surgical System. The ASC will also prov
What is the new name for Transenterix?
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc. The name change reflects the company's broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics. While the company name change is effective today, the company's stock will begin trading under the new ticker symbol, NYSE American: ASXC, and name, Asensus Surgical, Inc., at the open of trading on March 5, 2021.
How much is Transenterix revenue in 2020?
Progress for TransEnterix has been fairly slow. For 2020, the company estimates that revenues will range from $3 million to $3.2 million, compared to $8.5 million in 2020 and $24.1 million in 2018. No doubt, Covid-19 pandemic has definitely had an adverse impact on the company as there have been fewer medical procedures.
Is Transenterix changing its name?
TransEnterix (NYSEARCA: TRXC ), which is a medical devices company, announced this week that it will change its corporate name to Asensus Surgical, but there’s no telling how much that will matter to TRXC stock in the long term.
How many X is Zacks?
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
What are the different grades for stocks?
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
Is ZacksTrade a separate company?
ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
